Singapore markets closed

Rohto Pharmaceutical Co.,Ltd. (4527.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
3,264.00+19.00 (+0.59%)
At close: 03:15PM JST
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/03/2024
31/03/2023
31/03/2022
31/03/2021
Assets
Current assets
Cash
Cash and cash equivalents
89,210,000
79,951,000
72,791,000
52,964,000
Total cash
89,210,000
79,951,000
72,791,000
52,964,000
Net receivables
44,744,000
39,686,000
33,310,000
31,207,000
Inventory
46,657,000
41,062,000
33,527,000
27,925,000
Other current assets
34,148,000
29,547,000
24,678,000
20,975,000
Total current assets
214,759,000
190,246,000
164,306,000
133,071,000
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
182,408,000
172,644,000
162,113,000
136,666,000
Accumulated depreciation
-113,801,000
-106,462,000
-99,274,000
-86,877,000
Net property, plant and equipment
68,607,000
66,182,000
62,839,000
49,790,000
Goodwill
2,285,000
2,564,000
2,954,000
3,304,000
Intangible assets
6,932,000
6,997,000
6,587,000
4,590,000
Other long-term assets
-606,000
-1,009,000
-662,000
1,199,000
Total non-current assets
131,414,000
119,429,000
110,567,000
93,076,000
Total assets
346,175,000
309,677,000
274,876,000
226,149,000
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
5,304,000
4,177,000
8,033,000
2,312,000
Accounts payable
16,991,000
16,025,000
13,660,000
9,603,000
Other current liabilities
32,429,000
29,368,000
27,256,000
10,008,000
Total current liabilities
87,087,000
80,162,000
71,488,000
56,471,000
Non-current liabilities
Long-term debt
5,190,000
7,516,000
13,350,000
5,787,000
Deferred tax liabilities
1,597,000
1,173,000
1,537,000
998,000
Other long-term liabilities
2,683,000
2,604,000
1,122,000
1,156,000
Total non-current liabilities
12,055,000
14,439,000
19,396,000
13,067,000
Total liabilities
99,142,000
94,601,000
90,884,000
69,538,000
Stockholders' equity
Common stock
6,504,000
6,504,000
6,504,000
6,504,000
Retained earnings
209,399,000
184,005,000
162,304,000
145,511,000
Total stockholders' equity
246,323,000
209,568,000
178,398,000
155,907,000
Total liabilities and stockholders' equity
346,175,000
309,677,000
274,876,000
226,149,000